Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Biogen MA Inc. | Morrisville, NC, United States | Makes the active ingredient and tests it | No problems foundJun 13, 2018 · 9 inspections |
| Cilag AG | Schaffhausen, Switzerland | Makes it, tests it, packages it and labels it | No problems foundNov 21, 2025 · 8 inspections |
| FUJIFILM Diosynth Biotechnologies Denmark ApS | Hillerod, Denmark | Makes the active ingredient and tests it | Problems found, fixed voluntarilyJun 30, 2023 · 5 inspections |
| Janssen Biotech, Inc. | Malvern, PA, United States | Makes the active ingredient | Problems found, fixed voluntarilyJul 29, 2025 · 13 inspections |
| Janssen Sciences Ireland UC | CO Cork, Ireland | Makes the active ingredient and tests it | Problems found, fixed voluntarilyJan 12, 2024 · 5 inspections |
| Bioreliance Corporation | Rockville, MD, United States | Tests it | Problems found, fixed voluntarilyJan 29, 2026 · 7 inspections |
| Janssen Biologics B.V. | Leiden, Netherlands | Tests it | Problems found, fixed voluntarilyJun 1, 2023 · 7 inspections |
Product details
- Generic drug
- Amivantamab: every company that makes it
- Form
- injection, intravenous
- Strength
- 350 mg
- Approval
- BLA BLA761210
- On the market since
- May 21, 2021
- Package NDCs
57894-501-0057894-501-01- Official label
- DailyMed (National Library of Medicine), updated Nov 11, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?